Bell Rock Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-450
Closed -$29K 488
2018
Q4
$29K Sell
450
-420
-48% -$31K 0.02% 269
2018
Q3
$78K Sell
870
-2,000
-70% -$177K 0.04% 214
2018
Q2
$228K Sell
2,870
-2,092
-42% -$174K 0.12% 112
2018
Q1
$444K Sell
4,962
-9,660
-66% -$927K 0.24% 81
2017
Q4
$1.53M Buy
14,622
+3,277
+29% +$370K 0.82% 38
2017
Q3
$1.65M Buy
11,345
+995
+10% +$136K 0.94% 34
2017
Q2
$1.35M Buy
10,350
+10,290
+17,150% +$1.26M 0.83% 38
2017
Q1
$7K Hold
60
0.01% 313
2016
Q4
$7K Buy
+60
New +$6.68K 0.01% 310

Other funds holding CELG

Bell Rock Capital's CELG Position: Q1 2019 in Review

Bell Rock Capital sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 450 shares — an estimated $29K sold.

Bell Rock Capital first reported a position in CELG in Q4 2016 and held it in 9 quarters. The position peaked at $1.65M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Bell Rock Capital reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Bell Rock Capital sold 450 Celgene Corp shares in Q1 2019, an estimated $29K.
  • Bell Rock Capital first reported a position in Celgene Corp in Q4 2016 and held it in 9 quarters.
  • Bell Rock Capital's Celgene Corp position peaked at $1.65M in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Bell Rock Capital's 13F filing for Q1 2019, filed 8 Apr 2019.